Concurrent Chemoradiotherapy for Salvage in Relapsed Squamous Cell Head and Neck Cancer

References

• Pinto HA, Jacobs C: Chemotherapy for recurrent and metastatic head and neck cancer. Hematol Oncol Clin North Am 5:667485, 1991.
   Web of Science ®Google Scholar
• Pearlman NW: Treatment outcome in recurrent head and neck cancer. Arch Surg 11439–42, 1979.
   Google Scholar
• Emami B, Bignardi M, Spector GJ, et al: Reirradiation of recurrent head and neck cancers. Laryngoscope 97:8548, 1987.
   Web of Science ®Google Scholar
• Pomp J, Levendag PC, van Putten WLJ: Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol 11543–549, 1988.
   Google Scholar
• Levendag PC, Meeuwis CA, Visser AG: Reirradiation of recurrent head and neck cancers: External andor interstitial radiation therapy. Radiother Oncol 23:6–15, 1992.
   PubMed Web of Science ®Google Scholar
• Puthawala AA, Syed AMN: Interstitial re-irradiation for recurrent and/or persistent head and neck cancers. Int J Radiat Oncol Biol Phys 13:1113–1114, 1987.
   PubMed Web of Science ®Google Scholar
• Rate WR, Garrett P, Haniaker R, et al: Intraoperative radiation thcrapy for recurrent head and neck cancer. Cancer 67:2738–2740, 1991.
   PubMed Web of Science ®Google Scholar
• Deconti RC, Schoenfeld D: A randomized prospective coniparison of intermittent methotrexate, methotrexate with leucovorin, aid a niethotrexate conibination in head and neck cancer. Cancer 48: 1061–1072, 1981.
   PubMed Web of Science ®Google Scholar
• Vogl SE, Schoenfeld DA, Kaplan BH, et al: A randomized prospectivc comparison of methotrexate with a combination of nieihw trexate, bleomycin, and cisplatin in head and neck cancer. Cancer 56432442. 1985.
   Google Scholar
• The Liverpool Head and Neck Oncology Group: A phase 111 randomized trial of cisplatinum, methotrexate, cisplatinum + niethotrexate and cisplatinum + 5-FU in end stage squamous cell carcinoma of the head and neck. Br J Camxr 6131 1–315, 1990.
   Google Scholar
• Forastiere AA, Metch B, Schuller DE, et al: Randomized comparisou of cisplatin plus lluorouracil and carboplatin plus fluorouracil versus niethotrexate in advanced squanious-cell carcinoma of the head and neck A Southwest Oncology Group study. J Clin Oncol 10124.Fl251, 1992.
   Google Scholar
• Jacobs C, Lyman G, Velez-Garcia E, et al: A phase 111 randomized study comparing cisplatin and fluorouracil as single agents and in conibination for advanced squamous cell carcinoma of the head and ncck. J Clin Oncol 10257–263, 1992.
   Google Scholar
• Paccagnella A, Orlando A, Marchiori C, et al: Phase Ill trial of iiiitial chemotherapy in stage 111 or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer list 86265–272, 1994.
   Google Scholar
• Weissler MC, Melin S, Sailer SL, et al: Simultaneous chenioirradiation in the treatment of advanced head aud neck cancer. Arch Otolaryngol Head Neck Surg 118:806–810, 1992.
   PubMed Web of Science ®Google Scholar
• Taylor SG, Murthy AK, Caldarelli DD, et al: Conibiird simultaneous cisplatidfluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol7:846–856, 1989.
   Google Scholar
• Adelstein DJ, Sharan VM, Earle AS, et al: Long term results after chemoradiotherapy for locally confined squamouscell head and neck cancer. Am J Clin Oncol 13:440–447, 1990.
   PubMed Web of Science ®Google Scholar
• Adelstein DJ, Sharan VM, Earle AS, el al: Long-term follow-up of a prospective randomized trial comparing simultaneous and sequential chemoradiotherapy for squamous cell head and neck cancer. In: Adjuvant Therapy of Cancer VII, edited by SE Salmon, Philadelphia, JB Lippincott, 1993, pp 82–91.
   Google Scholar
• Adelstein DJ, Kalish LA, Adam GL, et al: Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: An Eastern Cooperative Oncology Group pilot study. J Clin Oncol 11:2136–2142, 1993.
   PubMed Web of Science ®Google Scholar
• Adelstein DJ, Lavertu P, Saxton JP, et al: Concurrent combination chemotherapy (CT) and continuous course radiotherapy (RT) for squamous cell head and neck caner (SCHNC): Toxicity and results. Head Neck 16:490, 1994 (abstract).
   Google Scholar
• Vermund H, Kaalhus 0, Winther F, et al: Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: A phase 111 clinical trial. Int J Radiat Oncd Biol Phys 11:1877–1886, 1985.
   PubMed Web of Science ®Google Scholar
• Eschwege F, Sancho-Garnier H, Gerard JP, et al: Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: Experience of the European Organization for Research and Treatnient of Cairer. Natl Cancer Inst Monogr 6275–278, 1988.
   Google Scholar
• Shigematsu Y, Sakai S, Fuchihata H: Recent trials in the treatment of maxillary sinus carcinoma, withspecial referencetothechemical potentiation of radiation therapy. Acta Otolaryngol 71:63–70, 1971.
   PubMed Web of Science ®Google Scholar
• Weissberg JV, Son YH, Papac RJ, el al: Randomized clinical trial of mitomycin-C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 173–9, 1989.
   Google Scholar
• Lo TCM, Wiley AL, Ansfield FJ, et al: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. Am J Roentgend 126:229–235, 1976.
   PubMed Web of Science ®Google Scholar
• Fu KK, Phillips TL, Silverberg IJ, et al: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 5: 1410–1418, 1987.
   PubMed Web of Science ®Google Scholar
• Vokes EE, Paiije WR, Weichselbaum RR, et al: Concomitant hydroxyurea, 5-fluorouracil, and radiation therapy for recurrent head and neck cancer: Early results. Otolaryngol Head Neck Surg 98–295-298, 1988.
   Google Scholar
• Haraf DJ, Vokes EE, Panje WR, et al: Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neckcancer. Am J Clin Oncol 14419426, 1991.
   Google Scholar
• Vokes EE, Haraf DJ, Mick R, el al: Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol 12:2351–2359, 1994.
   PubMed Web of Science ®Google Scholar
• Weppelmann B, Wheeler RH, Peters GE, et al: Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation. In1 J Radiat Oncol Biol Phys 221051–1056, 1992.
   Google Scholar
• Spencer S, Wheeler R, Peters G, el al: Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. Head Neck 16:498, 1994 (abstract).
   Google Scholar
• Gandia D, Wibault P, Guillot T, et al: Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neckcancer. Head Neck 158–15.1993.
   Google Scholar
• Uhlman D, Monyak D, Lee C, et al: Simultaneous chemotherapy and radiation therapy for recurrent squamous cell carcinoma of the head and neck. Prcc ASCO 11:248, 1992 (abstract).
   Google Scholar
• Hartsell WF, Thomas CR, Murthy AK, et al: Pilot study for the evaluation of simultaneous cisplatinl5-fluomracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (EST P-C385). Am J Clin Oncol 17:338–343,1994.
   PubMedGoogle Scholar
• Adelstein DJ: The community approach to salvage therapy for advanced head and neck cancer. Semin Onco1 21(Suppl 7):52–57, 1994.
   Google Scholar